Science Explorer Interactive view Map
Company · Oslo · Norway

Bayer (Norway)

bayer.noROR OpenAlex
Research works
54
◆ 0% vs 2013–17
Citations
1.7k
32.0 per fractional work
Top-10% rate
13.9%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Bayer (Norway) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.96× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 0.33× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.14× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.20× its world share, 0 worksChemistryComputer Science: 0.32× its world share, 0 worksComputer ScienceEngineering: 1.23× its world share, 2 worksEngineeringMathematics: 0.64× its world share, 0 worksMathematicsPhysics and Astronomy: 1.10× its world share, 0 worksPhysics and AstronomyDentistry: 0.87× its world share, 0 worksDentistryHealth Professions: 2.08× its world share, 0 worksHealth ProfessionsMedicine: 3.00× its world share, 5 worksMedicineBusiness, Management and Accounting: 0.15× its world share, 0 worksBusiness, Management…Decision Sciences: 1.76× its world share, 0 worksDecision SciencesSocial Sciences: 0.15× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.0×. Every wedge is a field page.

Which keywords describe research at Bayer (Norway)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Treatment, Targeted Therapy, PET Imaging, Dosimetry, Radioimmunotherapy, Radiopharmaceuticals, Clinical Trials and Genomic Profiling.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Treatment14▲ 99×4 topics
  2. Targeted Therapy13▲ 116×3 topics
  3. PET Imaging13▲ 110×3 topics
  4. Dosimetry12▲ 248×2 topics
  5. Radioimmunotherapy12▲ 568×1 topic
  6. Radiopharmaceuticals12▲ 568×1 topic
  7. Clinical Trials5▲ 15×3 topics
  8. Genomic Profiling5▲ 90×2 topics
  9. Genetic Mutations5▲ 17×4 topics
  10. Immunotherapy5▲ 13×6 topics
  11. Prostate Cancer5▲ 59×3 topics
  12. Biomarkers4▲ 12×3 topics
  13. Cancer4▲ 4.7×4 topics
  14. Androgen Receptor4▲ 71×1 topic
  15. Hormone Therapy4▲ 62×2 topics
  16. Metastatic Prostate Cancer4▲ 148×1 topic
  17. Imaging3▲ 14×3 topics
  18. Breast Cancer2▲ 16×4 topics
  19. Monoclonal Antibodies2▲ 29×2 topics
  20. PET/CT2▲ 55×1 topic
  21. Therapeutic Antibodies2▲ 32×2 topics
  22. tumor2▲ 55×1 topic
  23. Glycosylation2▲ 18×2 topics
  24. Antibody Engineering2▲ 38×1 topic
  25. Fc Receptors2▲ 38×1 topic
  26. Chemotherapy2▲ 4.7×4 topics
  27. Oxidative Stress2▲ 1.58×8 topics
  28. Cancer Therapy2▲ 4.5×4 topics
  29. Tumor Microenvironment2▲ 7.7×3 topics
  30. ALK Inhibitors1▲ 44×1 topic
  31. EGFR Mutations1▲ 44×1 topic
  32. Genomic Instability1▲ 19×2 topics
  33. Homologous Recombination1▲ 34×2 topics
  34. Medicinal Chemistry1▲ 5.8×3 topics
  35. Bisphosphonates1▲ 52×1 topic
  36. Clinical Practice Guidelines1▲ 3.8×2 topics
  37. HER21▲ 70×1 topic
  38. Osteonecrosis of the Jaw1▲ 52×1 topic
  39. Trastuzumab1▲ 50×1 topic
  40. Cardiovascular Disease1▲ 1.70×9 topics

Which research topics does Bayer (Norway) publish most on?

By volume in 2022–2025: Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Radiation Therapy and Dosimetry and Pluripotent Stem Cells Research.

Radiopharmaceutical Chem…2Radiopharmaceutical Chemistry and Applications: 2 fractional worksProstate Cancer Treatment and Research: 0 fractional worksRadiation Therapy and Dosimetry: 0 fractional worksPluripotent Stem Cells Research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksMedical Imaging Techniques and Applications: 0 fractional worksInnovative Microfluidic and Catalytic Techniques Innovation: 0 fractional works3D Printing in Biomedical Research: 0 fractional worksFault Detection and Control Systems: 0 fractional worksInformation Systems Theories and Implementation: 0 fractional works
Radiology, Nuclear Medicine and ImagingPulmonary and Respiratory MedicineMolecular BiologyOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  3. 3 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 0 works
  4. 4 Pluripotent Stem Cells Research Molecular Biology 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
  8. 8 3D Printing in Biomedical Research Biomedical Engineering 0 works
  9. 9 Fault Detection and Control Systems Control and Systems Engineering 0 works
  10. 10 Information Systems Theories and Implementation Sociology and Political Science 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.8%not open58.2%

World: 28% of research is openly available.

with international co-authors62.6%domestic only37.4%

World: 19% is written across borders.

How has Bayer (Norway)'s research output changed?

Output in 2018–2022 was 0% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Oslo

All research institutions in Oslo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.